Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes.
Published online
Journal Article
Full Text
- Published version (via Digital Object Identifier)
- Pubmed Central version
- Open Access Copy from Duke
- Link to Item
Duke Authors
Cited Authors
- Swords, RT; Watts, J; Erba, HP; Altman, JK; Maris, M; Anwer, F; Hua, Z; Stein, H; Faessel, H; Sedarati, F; Dezube, BJ; Giles, FJ; Medeiros, BC; DeAngelo, DJ
Published Date
- February 3, 2017
Published In
Volume / Issue
- 7 / 2
Start / End Page
- e520 -
PubMed ID
- 28157218
Pubmed Central ID
- 28157218
Electronic International Standard Serial Number (EISSN)
- 2044-5385
Digital Object Identifier (DOI)
- 10.1038/bcj.2017.1
Language
- eng
Conference Location
- United States